15 interventions in Supplement.
Coenzyme Q10 / Ubiquinol
One intriguing cardiovascular-mortality RCT (confounded by co-administered selenium) is the strongest evidence, and it does not generalize to healthy people or to aging broadly. Reasonable for specific cardiac contexts and statin-associated myalgia; oversold as a general anti-aging antioxidant.
Collagen Peptides
Decent evidence for skin and joint cosmesis, largely from company-funded trials, and essentially nothing about actual aging biology or lifespan. It is a targeted beauty/joint supplement wearing a longevity costume. Fine if you want the skin effect; not a geroprotector.
Creatine Monohydrate
Refreshingly, the evidence here is real and boring: creatine plus lifting reliably builds strength in older adults, and strength predicts survival. It is not a direct lifespan pill, but it is one of the best-supported, safest, cheapest tools for healthspan via muscle. Under-hyped relative to its evidence.
GlyNAC (Glycine + N-Acetylcysteine)
The reported effect sizes are almost too good, and that is exactly why skepticism is warranted: small, mostly single-lab, partly open-label trials showing improvement across nearly every hallmark at once. Biologically plausible and low-risk, but it needs large independent replication before the sweeping claims can be trusted.
NAD+ Precursors (NMN & Nicotinamide Riboside)
The classic 'raises a biomarker, therefore anti-aging' story. Yes, they raise NAD+. No, that has not translated into demonstrated healthspan or lifespan benefit in humans despite dozens of trials. One of the most over-marketed categories relative to its clinical evidence.
Sulforaphane
A legitimate NRF2 activator with real (non-aging) human trial signals, but zero evidence it slows aging or extends healthspan. 'Eat your cruciferous vegetables' is sound; 'sulforaphane is a proven longevity compound' is not.
Urolithin A
One of the few longevity supplements with multiple positive, properly controlled human RCTs, though the benefits are modest and about muscle/mitochondrial function, not proven lifespan. Reasonable evidence for a real (if small) healthspan effect. Less hype gap than most, but do not expect it to extend life.
Spermidine
Strong and attractive preclinical autophagy story with supportive epidemiology, but the single well-controlled human cognition RCT was flat-out negative. Marketed on mouse and correlational data; the best human trial did not deliver. Promising nutrient, not a proven intervention.
Taurine
Exploded from one 2023 Science paper into a viral 'anti-aging amino acid,' then the central biomarker claim (taurine declines with age) failed to replicate in a rigorous 2025 study. Cheap and safe, but the human longevity case is now genuinely in doubt. A vivid lesson in not building a supplement trend on a single unreplicated finding.
Alpha-Ketoglutarate (Calcium AKG)
The mouse morbidity-compression data is genuinely interesting, but the headline human claim ('8 years younger') comes from an uncontrolled retrospective methylation-clock analysis of a product sold by the study's backers, which is close to worthless as proof. Intriguing mechanism, marketing that vastly overstates the human evidence.
Fisetin
Marketed as a natural senolytic based almost entirely on one mouse study and cell screens, with essentially no positive human data and a real bioavailability problem. The enthusiasm outruns the evidence badly. Plausible, cheap, low-risk, but 'proven senolytic in people' is not true.
Omega-3 Fatty Acids (EPA/DHA)
The definitive large RCT (VITAL) was essentially null for hard outcomes in the general population, and omega-3 did not even move telomere length. Benefit is real but confined to specific high-risk cardiovascular subgroups at high doses. As a broad longevity supplement, the evidence is underwhelming.
Resveratrol
The archetype of longevity hype collapsing under scrutiny: discredited primary mechanism, negative ITP lifespan results, disappointing human trials, and terrible bioavailability. If any single supplement should have exited the longevity conversation, it is this one. Marketing far outlived the science.
Vitamin D
A perfect example of correlation vs causation: low vitamin D tracks with bad health, but supplementing replete people did not cut mortality or cancer in the definitive RCT. The 2025 telomere finding is intriguing and worth following, but as of now the honest story is 'fix deficiency, do not expect miracles from extra.'
TA-65 / Telomerase Activators (Cycloastragenol)
Expensive, heavily marketed on the seductive telomere theory, with only small often-conflicted trials, an alternative (immune-cell-shift) explanation for its main claimed effect, no outcome data, and an unresolved cancer concern. High price, weak and contested evidence: among the poorer value propositions in this list.